Overview of Macrophage Migration Inhibitory Factor (MIF) As a Potential Biomarker Relevant to Adiposity

Overview

Journal J Tradit Complement Med

Specialty Rehabilitation Medicine

Date 2014 Apr 10

PMID 24716131

Citations 6

Authors

Jun Nishihira

Shinji Sakaue

Affiliations

Soon will be listed here.

Abstract

The cytokine "macrophage migration inhibitory factor (MIF)" is generally recognized as a proinflammatory cytokine, and MIF is involved in broad range of acute and chronic inflammatory states. With regard to glucose metabolism and insulin secretion, MIF is produced by pancreatic β cells and acts as a positive regulator of insulin secretion. In contrast, it is evident that MIF expressed in adipose tissues causes insulin resistance. Concerning MIF gene analysis, we found four alleles: 5-, 6-, 7-and 8-CATT at position -794 of MIF gene in a Japanese population. Genotypes without the 5-CATT allele were more common in the obese subjects than in the lean or overweight groups. It is conceivable that promoter polymorphism in the MIF gene is profoundly linked with obesity relevant to lifestyle diseases, such as diabetes. Obesity has become a serious social issue due to the inappropriate nutritional balance, and the consumption of functional foods (including functional foods to reduce fat mass) is expected to overcome this issue. In this context, MIF would be a reliable quantitative biomarker to evaluate the effects of functional foods on adiposity.

Citing Articles

Genetic Variation of Gene rs2070766 Is Associated With Acute Coronary Syndromes in Chinese Population.

Zhang J, Zhao Q, Liu F, Li D, Men L, Luo J Front Genet. 2022; 12:750975.

PMID: 35046995 PMC: 8762351. DOI: 10.3389/fgene.2021.750975.

Macrophage inhibitory factor (MIF) gene polymorphisms are associated with disease susceptibility and with circulating MIF levels in active non-segmental vitiligo in patients from western Mexico.

Garcia-Orozco A, Martinez-Magana I, Riera-Leal A, Munoz-Valle J, Martinez-Guzman M, Quinones-Venegas R Mol Genet Genomic Med. 2020; 8(10):e1416.

PMID: 32705792 PMC: 7549602. DOI: 10.1002/mgg3.1416.

Regulation of MIF Enzymatic Activity by an Allosteric Site at the Central Solvent Channel.

Pantouris G, Khurana L, Ma A, Skeens E, Reiss K, Batista V Cell Chem Biol. 2020; 27(6):740-750.e5.

PMID: 32433911 PMC: 7388010. DOI: 10.1016/j.chembiol.2020.05.001.

Pleiotropic role of macrophage migration inhibitory factor in cancer.

Guda M, Rashid M, Asuthkar S, Jalasutram A, Caniglia J, Tsung A Am J Cancer Res. 2020; 9(12):2760-2773.

PMID: 31911860 PMC: 6943360.

Impact of MIF Gene Promoter Variations on Risk of Rheumatic Heart Disease and Its Age of Onset in Saudi Arabian Patients.

Abdallah A, Al-Mazroea A, Al-Harbi W, Al-Harbi N, Eldardear A, Almohammadi Y Front Immunol. 2016; 7:98.

PMID: 27014277 PMC: 4790191. DOI: 10.3389/fimmu.2016.00098.

References

Yabunaka N, Nishihira J, Mizue Y, Tsuji M, Kumagai M, Ohtsuka Y . Elevated serum content of macrophage migration inhibitory factor in patients with type 2 diabetes. Diabetes Care. 2000; 23(2):256-8. DOI: 10.2337/diacare.23.2.256. View

Donn R, Shelley E, Ollier W, Thomson W . A novel 5'-flanking region polymorphism of macrophage migration inhibitory factor is associated with systemic-onset juvenile idiopathic arthritis. Arthritis Rheum. 2001; 44(8):1782-5. DOI: 10.1002/1529-0131(200108)44:8<1782::AID-ART314>3.0.CO;2-#. View

Hizawa N, Yamaguchi E, Takahashi D, Nishihira J, Nishimura M . Functional polymorphisms in the promoter region of macrophage migration inhibitory factor and atopy. Am J Respir Crit Care Med. 2004; 169(9):1014-8. DOI: 10.1164/rccm.200307-933OC. View

Rice T, Chagnon Y, Perusse L, Borecki I, Ukkola O, Rankinen T . A genomewide linkage scan for abdominal subcutaneous and visceral fat in black and white families: The HERITAGE Family Study. Diabetes. 2002; 51(3):848-55. DOI: 10.2337/diabetes.51.3.848. View

Waeber G, Calandra T, Roduit R, Haefliger J, Bonny C, Thompson N . Insulin secretion is regulated by the glucose-dependent production of islet beta cell macrophage migration inhibitory factor. Proc Natl Acad Sci U S A. 1997; 94(9):4782-7. PMC: 20802. DOI: 10.1073/pnas.94.9.4782. View

Sakaue S, Ishimaru S, Hizawa N, Ohtsuka Y, Tsujino I, Honda T . Promoter polymorphism in the macrophage migration inhibitory factor gene is associated with obesity. Int J Obes (Lond). 2005; 30(2):238-42. DOI: 10.1038/sj.ijo.0803148. View

Bacher M, Metz C, Calandra T, Mayer K, Chesney J, Lohoff M . An essential regulatory role for macrophage migration inhibitory factor in T-cell activation. Proc Natl Acad Sci U S A. 1996; 93(15):7849-54. PMC: 38837. DOI: 10.1073/pnas.93.15.7849. View

Xu H, Barnes G, Yang Q, Tan G, Yang D, Chou C . Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest. 2003; 112(12):1821-30. PMC: 296998. DOI: 10.1172/JCI19451. View

Hotamisligil G, Shargill N, Spiegelman B . Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science. 1993; 259(5091):87-91. DOI: 10.1126/science.7678183. View

10.

Bernhagen J, Calandra T, Mitchell R, Martin S, Tracey K, Voelter W . MIF is a pituitary-derived cytokine that potentiates lethal endotoxaemia. Nature. 1993; 365(6448):756-9. DOI: 10.1038/365756a0. View

11.

David J . Delayed hypersensitivity in vitro: its mediation by cell-free substances formed by lymphoid cell-antigen interaction. Proc Natl Acad Sci U S A. 1966; 56(1):72-7. PMC: 285677. DOI: 10.1073/pnas.56.1.72. View

12.

Calandra T, Bernhagen J, Mitchell R, Bucala R . The macrophage is an important and previously unrecognized source of macrophage migration inhibitory factor. J Exp Med. 1994; 179(6):1895-902. PMC: 2191507. DOI: 10.1084/jem.179.6.1895. View

13.

Nishihira J . Novel pathophysiological aspects of macrophage migration inhibitory factor (review). Int J Mol Med. 1998; 2(1):17-28. DOI: 10.3892/ijmm.2.1.17. View

14.

Nishihira J . Macrophage migration inhibitory factor (MIF): its essential role in the immune system and cell growth. J Interferon Cytokine Res. 2000; 20(9):751-62. DOI: 10.1089/10799900050151012. View

15.

Weisberg S, McCann D, Desai M, Rosenbaum M, Leibel R, Ferrante Jr A . Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest. 2003; 112(12):1796-808. PMC: 296995. DOI: 10.1172/JCI19246. View

16.

Benigni F, Atsumi T, Calandra T, Metz C, Echtenacher B, Peng T . The proinflammatory mediator macrophage migration inhibitory factor induces glucose catabolism in muscle. J Clin Invest. 2000; 106(10):1291-300. PMC: 381433. DOI: 10.1172/JCI9900. View

17.

Bernhagen J, Calandra T, Bucala R . Regulation of the immune response by macrophage migration inhibitory factor: biological and structural features. J Mol Med (Berl). 1998; 76(3-4):151-61. DOI: 10.1007/s001090050204. View

18.

Hotamisligil G, Arner P, Caro J, Atkinson R, Spiegelman B . Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance. J Clin Invest. 1995; 95(5):2409-15. PMC: 295872. DOI: 10.1172/JCI117936. View

19.

Bucala R . MIF re-discovered: pituitary hormone and glucocorticoid-induced regulator of cytokine production. Cytokine Growth Factor Rev. 1996; 7(1):19-24. DOI: 10.1016/1359-6101(96)00008-1. View

20.

Bloom B, Bennett B . Mechanism of a reaction in vitro associated with delayed-type hypersensitivity. Science. 1966; 153(3731):80-2. DOI: 10.1126/science.153.3731.80. View